Table 5.
Independent effect of age of blood cells in the prime, allogeneic donor exposure and platelet count at the end of bypass on clinical outcomes
| Univariate MLE analysis |
||||
|---|---|---|---|---|
| PE | SE | P value | Multivariable P value | |
| Higher chest tube loss at 24 hours | ||||
| Lower platelet count at the end of bypass (×109/L) | −0.0026 | (0.0004) | <.0001 | <.0001 |
| Older age of blood product in prime (d) | 0.0120 | (0.0010) | <.0001 | <.0001 |
| Higher number of allogeneic donors exposure | 0.0241 | (0.0024) | <.0001 | .06 |
| Higher inotropic score at 24 hours | ||||
| Lower platelet count at the end of bypass (×109/L) | −0.0029 | (0.0012) | .02 | .004 |
| Older age of blood product in prime (d) | 0.0087 | (0.0029) | .003 | .10 |
| Higher number of allogeneic donors exposure | 0.0310 | (0.0064) | <.0001 | .005 |
| Longer duration of ventilation (h) | ||||
| Lower platelet count at the end of bypass (×109/L) | −0.0041 | (0.0002) | <.0001 | <.0001 |
| Older age of blood product in prime (d) | 0.0129 | (0.0005) | <.0001 | <.0001 |
| Higher number of allogeneic donors exposure | 0.0206 | (0.0012) | <.0001 | <.0001 |
| Longer duration of hospital stay (d) | ||||
| Lower platelet count at the end of bypass (×109/L) | −0.0042 | (0.0007) | <.0001 | <.0001 |
| Older age of blood product in prime (d) | 0.0102 | (0.0016) | <.0001 | <.0001 |
| Higher number of allogeneic donors exposure | 0.0161 | (0.0039) | <.0001 | .67 |
Parameters are reported for the univariate associations while P values are reported for both univariate and multivariable associations. MLE, Maximum likelihood estimate; PE, parameter estimate; SE, standard error.